ELITE PHARMACEUTICALS INC /NV/ (ELTP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q1 '11: 831.9K Q2 '11: 994.6K Q3 '11: 1.2M Q4 '11: 1.2M Q1 '12: 990K Q2 '12: 274.1K Q3 '12: 509.9K Q4 '12: 650.1K Q1 '13: 578.6K Q2 '13: 634.5K Q3 '13: 667.7K Q4 '13: 1.5M Q1 '14: 721.7K Q2 '14: 1.2M Q3 '14: 1.7M Q4 '14: 1M Q1 '15: 1.2M Q2 '15: 1.3M Q3 '15: 1.4M Q4 '15: 1.2M Q1 '16: 2.2M Q2 '16: 2.9M Q3 '16: 2.2M Q4 '16: 5.2M Q1 '17: 3.3M Q2 '17: 2.7M Q3 '17: 2.3M Q4 '17: 1.4M Q1 '18: 1.7M Q2 '18: 1.6M Q3 '18: 2.5M Q4 '18: 1.6M Q1 '19: 2.2M Q2 '19: 1.4M Q3 '19: 2.7M Q4 '19: 1.3M Q1 '20: 3.4M Q2 '20: 4.6M Q3 '20: 5.1M Q4 '20: 4.9M Q1 '21: 7.5M Q2 '21: 7.4M Q3 '21: 6M Q4 '21: 4.4M Q1 '22: 7.1M Q2 '22: 8.6M Q3 '22: 9M Q4 '22: 7.7M Q1 '23: 7.7M Q2 '23: 8.6M Q3 '23: 9.3M Q4 '23: 8.6M Q1 '24: 9M Q2 '24: 14.2M Q3 '24: 15.5M Q4 '24: 17.9M Q1 '25: 18.8M Q2 '25: 18.9M Q3 '25: 14.4M Q4 '25: 32M Q1 '26: 40.2M Q2 '26: 36.3M Q3 '26: 31.6M Q4 '26: 40.7M Q1 '27: 32.4M Q2 '11 Q3 '13 Q4 '15 Q1 '18 Q2 '20 Q3 '22 Q4 '24 Q1 '27

Gross Profit Quarterly

-10M 0 10M 20M 30M Q1 '11: 420.2K Q2 '11: 429K Q3 '11: 584.8K Q4 '11: 156.8K Q1 '12: 564.6K Q2 '12: 197.8K Q3 '12: 353.3K Q4 '12: 294.7K Q1 '13: 124.2K Q2 '13: 154.9K Q3 '13: 400.9K Q4 '13: 408.4K Q1 '14: 142.7K Q2 '14: 542.3K Q3 '14: 698.7K Q4 '14: -18K Q1 '15: 433.2K Q2 '15: 574.7K Q3 '15: 663.2K Q4 '15: 331K Q1 '16: 966.1K Q2 '16: 1.5M Q3 '16: 1.4M Q4 '16: 4.2M Q1 '17: 1.1M Q2 '17: 834.9K Q3 '17: 603.9K Q4 '17: 1.2M Q1 '18: 687.7K Q2 '18: 1M Q3 '18: 1.1M Q4 '18: 1.1M Q1 '19: 591.3K Q2 '19: 820.5K Q3 '19: 922.8K Q4 '19: 532.9K Q1 '20: 1.3M Q2 '20: 1.3M Q3 '20: 2.9M Q4 '20: 2.5M Q1 '21: 3M Q2 '21: 3.6M Q3 '21: 3.4M Q4 '21: 1.9M Q1 '22: 3.6M Q2 '22: 3.8M Q3 '22: 4M Q4 '22: 3.4M Q1 '23: 4M Q2 '23: 3.8M Q3 '23: 4.9M Q4 '23: 3.4M Q1 '24: 4.8M Q2 '24: 6.4M Q3 '24: 7M Q4 '24: 8.1M Q1 '25: 8.5M Q2 '25: 8.2M Q3 '25: 6.1M Q4 '25: 17.3M Q1 '26: 27.2M Q2 '26: 14.1M Q3 '26: 13M Q4 '26: 20.8M Q1 '27: 13.5M Q2 '11 Q3 '13 Q4 '15 Q1 '18 Q2 '20 Q3 '22 Q4 '24 Q1 '27

Operating Income Quarterly

-8M 0 8M 16M 24M Q1 '11: -96.8K Q2 '11: -136.8K Q3 '11: 72.9K Q4 '11: -730.3K Q1 '12: -336.5K Q2 '12: -591.6K Q3 '12: -430.9K Q4 '12: -607.1K Q1 '13: -485.8K Q2 '13: -515.3K Q3 '13: -274.2K Q4 '13: -287.9K Q1 '14: -975.6K Q2 '14: -686.6K Q3 '14: -1.2M Q4 '14: -2.4M Q1 '15: -4.4M Q2 '15: -4.1M Q3 '15: -2.6M Q4 '15: -5.5M Q1 '16: -2.4M Q2 '16: -3.8M Q3 '16: -2.7M Q4 '16: 571K Q1 '17: -1.2M Q2 '17: -1.2M Q3 '17: -1.7M Q4 '17: -3.2M Q1 '18: -2.2M Q2 '18: -2.1M Q3 '18: -2.1M Q4 '18: -2.6M Q1 '19: -1.9M Q2 '19: -2.7M Q3 '19: -2.6M Q4 '19: -2M Q1 '20: -1.1M Q2 '20: -454.5K Q3 '20: 691.2K Q4 '20: -1.4M Q1 '21: 830.6K Q2 '21: 1.3M Q3 '21: 1M Q1 '22: 965.2K Q2 '22: 1.4M Q3 '22: 1.8M Q4 '22: 851.7K Q1 '23: 1M Q2 '23: 1.1M Q3 '23: 2M Q1 '24: 1.6M Q2 '24: 1.9M Q3 '24: 3.5M Q4 '24: 3.7M Q1 '25: 3.9M Q2 '25: 3.5M Q3 '25: 1.1M Q4 '25: 11.2M Q1 '26: 21.7M Q2 '26: 8.2M Q3 '26: 9M Q4 '26: 10.2M Q1 '27: 7.5M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q4 '22 Q1 '25 Q1 '27

Net Income Quarterly

-90M -60M -30M 0 30M 60M 90M Q1 '11: -4.8M Q2 '11: 1.9M Q3 '11: 5.9M Q4 '11: -16.6M Q1 '12: -30.7M Q2 '12: 13.9M Q3 '12: 8.8M Q4 '12: -7M Q1 '13: -10.5M Q2 '13: 1M Q3 '13: 9.4M Q4 '13: 1.6M Q1 '14: 921.7K Q2 '14: -9.6M Q3 '14: -1.1M Q4 '14: -86.8M Q1 '15: -2.1M Q2 '15: 6.2M Q3 '15: 7.4M Q4 '15: -6.3M Q1 '16: 4.7M Q2 '16: -1.7M Q3 '16: -12.2M Q4 '16: 8.5M Q1 '17: 1.1M Q2 '17: 4.2M Q3 '17: 1.7M Q4 '17: -3.2M Q1 '18: -2.2M Q2 '18: 1.8M Q3 '18: -490.2K Q4 '18: -2.8M Q1 '19: -1.7M Q2 '19: -2.6M Q3 '19: -2.3M Q4 '19: -2.7M Q1 '20: 279.7K Q2 '20: -1.6M Q3 '20: -1.9M Q4 '20: 936.4K Q1 '21: 1.1M Q2 '21: 2.5M Q3 '21: 2M Q1 '22: 2.4M Q2 '22: 1.8M Q3 '22: 2.3M Q4 '22: 2.4M Q1 '23: 305.9K Q2 '23: 1.5M Q3 '23: 3M Q1 '24: 1.1M Q2 '24: 14.9M Q3 '24: 706.4K Q4 '24: 3.3M Q1 '25: 615.8K Q2 '25: -11M Q3 '25: -10.9M Q4 '25: 17M Q1 '26: -5.9M Q2 '26: 13.7M Q3 '26: 18.6M Q4 '26: 18.5M Q1 '27: 5.9M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q4 '22 Q1 '25 Q1 '27

Cost of Revenue Quarterly

0 8M 16M 24M Q1 '11: 411.7K Q2 '11: 565.6K Q3 '11: 641.5K Q4 '11: 1.1M Q1 '12: 425.4K Q2 '12: 76.3K Q3 '12: 156.6K Q4 '12: 355.4K Q1 '13: 454.4K Q2 '13: 479.6K Q3 '13: 266.8K Q4 '13: 1.1M Q1 '14: 579K Q2 '14: 616.6K Q3 '14: 994.6K Q4 '14: 1M Q1 '15: 728.5K Q2 '15: 681.7K Q3 '15: 699.7K Q4 '15: 904K Q1 '16: 1.2M Q2 '16: 1.4M Q3 '16: 835.7K Q4 '16: 1M Q1 '17: 2.1M Q2 '17: 1.9M Q3 '17: 1.7M Q4 '17: 172K Q1 '18: 1M Q2 '18: 614.9K Q3 '18: 1.4M Q4 '18: 461K Q1 '19: 1.6M Q2 '19: 542.6K Q3 '19: 1.8M Q4 '19: 810.9K Q1 '20: 2.1M Q2 '20: 3.3M Q3 '20: 2.2M Q4 '20: 2.5M Q1 '21: 4.6M Q2 '21: 3.8M Q3 '21: 2.6M Q4 '21: 2.5M Q1 '22: 3.5M Q2 '22: 4.8M Q3 '22: 5M Q4 '22: 4.3M Q1 '23: 3.7M Q2 '23: 4.8M Q3 '23: 4.3M Q4 '23: 5.2M Q1 '24: 4.2M Q2 '24: 7.7M Q3 '24: 8.5M Q4 '24: 9.8M Q1 '25: 10.3M Q2 '25: 10.7M Q3 '25: 8.2M Q4 '25: 14.7M Q1 '26: 13M Q2 '26: 22.2M Q3 '26: 18.6M Q4 '26: 20M Q1 '27: 18.8M Q2 '11 Q3 '13 Q4 '15 Q1 '18 Q2 '20 Q3 '22 Q4 '24 Q1 '27

Operating Cash Flow Quarterly

-6M 0 6M 12M 18M Q1 '11: 50.2K Q2 '11: 304.6K Q3 '11: -36.3K Q4 '11: 1.2M Q1 '12: 239.1K Q2 '12: -469.4K Q3 '12: -558.7K Q4 '12: 395K Q1 '13: -297.4K Q2 '13: -842.4K Q3 '13: -326.9K Q4 '13: -476.7K Q1 '14: -355K Q2 '14: -929.7K Q3 '14: -1.5M Q4 '14: -1.5M Q1 '15: -4.2M Q2 '15: -4.4M Q3 '15: -2.6M Q4 '15: -3.9M Q1 '16: 1.9M Q2 '16: -3.5M Q3 '16: -1.8M Q4 '16: 606.4K Q1 '17: -764.2K Q2 '17: -2.3M Q3 '17: -726.4K Q4 '17: -4.1M Q1 '18: -1.1M Q2 '18: -2.2M Q3 '18: -478.1K Q4 '18: -1M Q1 '19: -1.7M Q2 '19: -1.7M Q3 '19: -1.3M Q4 '19: -2.1M Q1 '20: 188.3K Q2 '20: -463.8K Q3 '20: -312.2K Q4 '20: -1.2M Q1 '21: 807.4K Q2 '21: 1.9M Q3 '21: 1.2M Q1 '22: 1.7M Q2 '22: 153.8K Q3 '22: 3M Q4 '22: 1.6M Q1 '23: -557.5K Q2 '23: 1.5M Q3 '23: -567.9K Q4 '23: 3M Q1 '24: -2.7M Q2 '24: -235.9K Q3 '24: -2.4M Q4 '24: 2.1M Q1 '25: 3.1M Q2 '25: 1.5M Q3 '25: -1.1M Q4 '25: 3.9M Q1 '26: 14.8M Q2 '26: 5.1M Q3 '26: -5.3M Q4 '26: 9.1M Q1 '27: 10.1M Q4 '12 Q4 '14 Q4 '16 Q4 '18 Q4 '20 Q1 '23 Q1 '25 Q1 '27

Free Cash Flow Quarterly

-10M -5M 0 5M 10M 15M Q1 '11: 38.1K Q2 '11: 292.9K Q3 '11: -48K Q4 '11: 1.1M Q1 '12: 209.2K Q2 '12: -489.4K Q3 '12: -587.4K Q4 '12: 271.7K Q1 '13: -305.4K Q2 '13: -930.5K Q3 '13: -341.5K Q4 '13: -485.4K Q1 '14: -390.6K Q2 '14: -1M Q3 '14: -1.7M Q4 '14: -1.6M Q1 '15: -4.9M Q2 '15: -4.8M Q3 '15: -3M Q4 '15: -4.4M Q1 '16: 1.2M Q2 '16: -4.2M Q3 '16: -1.8M Q4 '16: 39.5K Q1 '17: -1M Q2 '17: -2.5M Q3 '17: -1M Q4 '17: -4.4M Q1 '18: -1.4M Q2 '18: -2.3M Q3 '18: -573.6K Q4 '18: -1.1M Q1 '19: -1.9M Q2 '19: -1.9M Q3 '19: -1.3M Q4 '19: -2.1M Q1 '20: 185.3K Q2 '20: -464K Q3 '20: -312.2K Q4 '20: -1.2M Q1 '21: 793.4K Q2 '21: 1.8M Q3 '21: 1.2M Q1 '22: 1.7M Q2 '22: 6.4K Q3 '22: 3M Q4 '22: 1.3M Q1 '23: -652.1K Q2 '23: -3.6M Q3 '23: -568.6K Q4 '23: 2.4M Q4 '24: 1.7M Q1 '25: 2.4M Q2 '25: 1.4M Q3 '25: -1.1M Q4 '25: 3.2M Q1 '26: 14.6M Q2 '26: 5M Q3 '26: -5.5M Q4 '26: 8.7M Q1 '27: 9.3M Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q2 '22 Q1 '25 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150B 300B 450B Q2 '11: 300M Q3 '11: 307.8B Q1 '12: 232M Q2 '12: 454.2M Q3 '12: 427M Q1 '13: 337.3M Q2 '13: 505.8M Q3 '13: 486.2M Q1 '14: 580.4M Q2 '14: 422M Q3 '14: 508.6M Q1 '15: 733.9M Q2 '15: 739.9M Q3 '15: 770.6M Q1 '16: 812.6M Q2 '16: 823.5M Q3 '16: 684.8M Q1 '17: 722.8M Q2 '17: 816M Q3 '17: 910.5M Q1 '18: 819.3M Q2 '18: 788.8M Q3 '18: 795.1M Q1 '19: 803M Q2 '19: 812.3M Q3 '19: 819.5M Q1 '20: 827.5M Q2 '20: 829.4M Q3 '20: 829.4M Q1 '21: 1B Q2 '21: 913.6M Q3 '21: 1B Q1 '22: 1B Q2 '22: 1B Q3 '22: 1B Q1 '23: 1B Q2 '23: 1B Q3 '23: 1B Q1 '24: 1B Q2 '24: 1B Q3 '24: 1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1.1B Q1 '26: 1.1B Q2 '26: 1.1B Q3 '26: 1.1B Q1 '27: 1.1B Q1 '13 Q1 '15 Q1 '17 Q1 '19 Q1 '21 Q1 '23 Q1 '25 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.21 -0.14 -0.07 0.00 0.07 0.14 0.21 Q4 '12: -0.06 Q1 '13: 0.04 Q2 '13: 0.01 Q3 '13: -0.01 Q4 '13: 0.00 Q1 '14: 0.03 Q2 '14: 0.01 Q3 '14: 0.01 Q4 '14: -0.18 Q1 '16: -0.03 Q2 '17: -0.05 Q3 '17: 0.00 Q4 '17: -0.01 Q1 '18: -0.01 Q2 '18: -0.01 Q3 '18: -0.01 Q4 '18: 0.00 Q1 '19: 0.00 Q2 '19: 0.00 Q3 '19: 0.00 Q4 '19: 0.00 Q1 '20: 0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.01 Q1 '23: 0.01 Q2 '23: 0.01 Q3 '23: 0.01 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.01 Q3 '24: 0.01 Q4 '24: 0.01 Q1 '25: 0.01 Q2 '25: -0.01 Q3 '25: -0.02 Q4 '25: 0.00 Q1 '26: -0.01 Q2 '26: 0.01 Q3 '26: 0.03 Q4 '26: 0.02 Q1 '27: 0.04 Q4 '12 Q3 '14 Q2 '18 Q1 '20 Q4 '21 Q3 '23 Q2 '25 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.